Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Diseases

Explore clinical trials studying Neuromuscular Diseases. Study availability and eligibility vary by location and protocol.

7,111 public trials 1,301 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Diseases trial results

Active, Not Recruiting

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

NCT05882734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • UCLA Hematology and Oncology - Santa Monica Santa Monica, California, United States
  • UPMC Cancer Center Pittsburgh, Pennsylvania, United States
  • Tennessee Cancer Specialists - Biomedical Research Knoxville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

Sporadic Inclusion Body Myositis Natural History Study

NCT05046821

Conditions
Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)

NCT05067790

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Rare Disease Research, LLC Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

NCT05881408

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • University of California at Davis Medical Center Sacramento, California, United States
  • Rady Children's Hospital-San Diego San Diego, California, United States
View all 46 locations
View Trial Details

Related conditions